Dr. Reddy's Laboratories launches FDA-approved wearable migraine device Nerivio in Germany, entering digital therapeutics in Europe.

Dr. Reddy's Laboratories has launched its wearable migraine management device, Nerivio, in Germany, marking its entry into digital therapeutics in Europe. The non-invasive device, approved by the US FDA and holding the CE-mark certification in Europe, uses Remote Electrical Neuromodulation (REN) to alleviate migraines. The company plans to introduce Nerivio in Spain and the UK in the coming months.